What is Scope Fluidics Spolka Akcyjna Days Payable?
Scope Fluidics Spolka AkcyjnaWAR:SCP -1.32%49 Days Payable is 570.60 as of Mar. 2026, which is 164% above its 10-year median of 215.73. GuruFocus rates WAR:SCP with a GF Score™ of 49/100 and a GF Value™ of zł129.86 (Fairly Valued). The stock has 4 warning signs investors should review. Among 190 Medical Diagnostics & Research companies, Scope Fluidics Spolka Akcyjna ranks better than 86.32% on this metric.
The historical rank and industry rank for Scope Fluidics Spolka Akcyjna's Days Payable or its related term are showing as below:
WAR:SCP'
s Days Payable Range Over the Past 10 Years
Min: 97.79 Med: 215.73 Max: 419.11
Current: 292.42
During the past 10 years, Scope Fluidics Spolka Akcyjna's highest Days Payable was 419.11. The lowest was 97.79. And the median was 215.73.
WAR:SCP's Days Payable is ranked better than 86.32% of 190
companies
in the Medical Diagnostics & Research industry
Industry Median: 65.385
vs WAR:SCP: 292.42
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:SCP vs TMO, DHR, IDXX: Days Payable Comparison
For the Diagnostics & Research subindustry, Scope Fluidics Spolka Akcyjna's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Scope Fluidics Spolka Akcyjna Days Payable vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Scope Fluidics Spolka Akcyjna's Days Payable distribution charts can be found below:
* The bar in red indicates where Scope Fluidics Spolka Akcyjna's Days Payable falls into.
Scope Fluidics Spolka Akcyjna Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scope Fluidics Spolka Akcyjna (WAR:SCP) has a Days Payable of 570.60 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Scope Fluidics Spolka Akcyjna and its competitors. This is 164% above median its historical median of 215.73. Over the past decade, Scope Fluidics Spolka Akcyjna's Days Payable has ranged from 97.79 to 419.11. According to the industry distribution chart, Scope Fluidics Spolka Akcyjna ranks #26 out of 190 companies in the Medical Diagnostics & Research industry, placing it in the top 13.7%.
Is Scope Fluidics Spolka Akcyjna's Days Payable too high?
Scope Fluidics Spolka Akcyjna's current Days Payable of 570.60 is 164% above median its 10-year median of 215.73. Over the past 10 years, this metric has ranged from a low of 97.79 to a high of 419.11. The Medical Diagnostics & Research industry median Days Payable is 65.39. Scope Fluidics Spolka Akcyjna's value of 570.60 is 772.7% above this industry median. Based on the distribution chart, Scope Fluidics Spolka Akcyjna ranks #26 out of 190 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Scope Fluidics Spolka Akcyjna has a GF Score™ of 49/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Scope Fluidics Spolka Akcyjna's Days Payable compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Scope Fluidics Spolka Akcyjna ranks #26 out of 190 companies for Days Payable. This places Scope Fluidics Spolka Akcyjna in the top 14% of its industry — outperforming the majority of peers. The industry median Days Payable is 65.39. Scope Fluidics Spolka Akcyjna's value of 570.60 is 772.7% above this benchmark. Historically, Scope Fluidics Spolka Akcyjna's own Days Payable has ranged from 97.79 to 419.11 over the past decade. While the company's 10-year median is 215.73 vs. the industry median of 65.39, Scope Fluidics Spolka Akcyjna has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 65.39, based on 190 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Scope Fluidics Spolka Akcyjna's current Days Payable of 570.60 is 772.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Scope Fluidics Spolka Akcyjna and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 65.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Scope Fluidics Spolka Akcyjna's current Days Payable is 570.60, which is 164% above median its own 10-year median of 215.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scope Fluidics Spolka Akcyjna stock overvalued right now?
Based on GuruFocus' analysis, Scope Fluidics Spolka Akcyjna (WAR:SCP) is currently considered Fairly Valued. The stock's GF Value™ is zł129.86, compared to a current price of zł120.00 — trading 7.6% below its estimated fair value. The current Days Payable is 570.60, which is 164% above median its 10-year median of 215.73 and 772.7% above the Medical Diagnostics & Research industry median of 65.39. Scope Fluidics Spolka Akcyjna's overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Scope Fluidics Spolka Akcyjna (WAR:SCP), the current Days Payable is 570.60 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Scope Fluidics Spolka Akcyjna (WAR:SCP) Overvalued in 2026?
Based on GuruFocus' analysis, Scope Fluidics Spolka Akcyjna stock appears to be undervalued.
The current stock price of zł120.00 is trading 7.6% below its estimated GF Value™ of zł129.86.
GuruFocus considers Scope Fluidics Spolka Akcyjna to be Fairly Valued.
Key valuation signals for WAR:SCP:
Days Payable: 570.60 (164% above median its 10-year median of 215.73)
GF Value™: zł129.86 vs. price of zł120.00 (7.6% below fair value)
Industry Position: 772.7% above the Medical Diagnostics & Research median (#26 of 190)
No single metric tells the full story. See the WAR:SCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Scope Fluidics Spolka Akcyjna Business Description
Scope Fluidics Spolka Akcyjna focuses on global challenges in health to develop diagnostic and med tech solutions. The company combines the expertise in microfluidic technology with the awareness of the challenges in medical diagnostics. It provides prototyping support for diagnostic services.
49GF Score
Get the complete analysis for WAR:SCP
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:SCP has been successfully added to your 
